Matsuzawa A, Moriyama T, Kaneko T, Tanaka M, Kimura M, Ikeda H, Katagiri T
Laboratory Animal Research Center, University of Tokyo, Japan.
J Exp Med. 1990 Feb 1;171(2):519-31. doi: 10.1084/jem.171.2.519.
Several mice with generalized lymphadenopathy were found in the CBA/KlJms (CBA) colony maintained at our institute. A new mutant strain of mice that develop massive lymphoid hyperplasia at 100% incidence within 5 mo after birth was established by crossing these diseased mice. Genetic studies on lymphadenopathy were conducted in F1, F2, and backcross populations from crosses between mutant CBA (CBA-m) and various inbred strains of mice. The results supported the control of lymphadenopathy by a single autosomal recessive gene. Since C3H/He-gld/gld (C3H-gld), MRL/MpJ-lpr/lpr (MRL-lpr), and C3H/HeJ-lpr/lpr (C3H-lpr) mice develop the same type of lymphoid hyperplasia, allelism of the mutant gene with gld or lpr was tested by investigating lymphadenopathy in F1 and backcross populations from crosses between CBA-m and C3H-gld, MRL-lpr, or C3H-lpr mice. The gene was confirmed to be allelic with lpr but not with gld. Interestingly, however, the mutant gene interacted with gld to induce less severe lymphadenopathy. Thus, the mutant gene was named lprcg, an lpr gene complementing gld in induction of lymphoproliferation. The genetic conclusion was supported by the same profile of surface markers of lymphoid cells with gld/gld, lpr/lpr, lprcg/lprcg, lprcg/lpr, and +/gld +/lprcg genotypes, as well as by massive lymph node hyperplasia and high titers of autoantibodies in the first four genotypes, but slight hyperplasia and insignificant autoantibody production in the last. The discovery of lprcg provided strong genetic evidence for the parallels between anomalous phenotypes of gld and lpr, and CBA/KlJms-lprcg/lprcg mice will contribute to elucidation of the mechanism of induction of the same abnormal differentiation and functions of lymphocytes by gld and lpr.
在我们研究所饲养的CBA/KlJms(CBA)种群中发现了几只患有全身性淋巴结病的小鼠。通过将这些患病小鼠杂交,建立了一种新的突变小鼠品系,该品系在出生后5个月内100%发生大量淋巴样增生。对突变CBA(CBA-m)与各种近交系小鼠杂交产生的F1、F2和回交群体进行了淋巴结病的遗传学研究。结果支持由单个常染色体隐性基因控制淋巴结病。由于C3H/He-gld/gld(C3H-gld)、MRL/MpJ-lpr/lpr(MRL-lpr)和C3H/HeJ-lpr/lpr(C3H-lpr)小鼠会发生相同类型的淋巴样增生,通过研究CBA-m与C3H-gld、MRL-lpr或C3H-lpr小鼠杂交产生的F1和回交群体中的淋巴结病,测试了突变基因与gld或lpr的等位性。该基因被证实与lpr等位,但与gld不等位。然而,有趣的是,突变基因与gld相互作用,导致较轻的淋巴结病。因此,该突变基因被命名为lprcg,即在诱导淋巴细胞增殖方面与gld互补的lpr基因。淋巴样细胞表面标志物的相同特征,以及前四种基因型中的大量淋巴结增生和高滴度自身抗体,但最后一种基因型中的轻微增生和不显著的自身抗体产生,支持了这一遗传学结论。lprcg的发现为gld和lpr异常表型之间的相似性提供了有力的遗传学证据,CBA/KlJms-lprcg/lprcg小鼠将有助于阐明gld和lpr诱导淋巴细胞相同异常分化和功能的机制。